Next Article in Journal
Unraveling the Hippocampal Molecular and Cellular Alterations behind Tramadol and Tapentadol Neurobehavioral Toxicity
Next Article in Special Issue
Descriptive Analysis of Adverse Events Reported for New Multiple Myeloma Medications Using FDA Adverse Event Reporting System (FAERS) Databases from 2015 to 2022
Previous Article in Journal
Chlorogenic Acid as a Potential Therapeutic Agent for Cholangiocarcinoma
Previous Article in Special Issue
Pharmacovigilance Practices by Healthcare Providers in Oncology: A Cross-Sectional Study
 
 
Systematic Review

Article Versions Notes

Pharmaceuticals 2024, 17(6), 795; https://doi.org/10.3390/ph17060795
Action Date Notes Link
article xml file uploaded 17 June 2024 13:13 CEST Original file -
article xml uploaded. 17 June 2024 13:13 CEST Update https://www.mdpi.com/1424-8247/17/6/795/xml
article pdf uploaded. 17 June 2024 13:13 CEST Version of Record https://www.mdpi.com/1424-8247/17/6/795/pdf
article supplementary file uploaded. 17 June 2024 13:13 CEST - https://www.mdpi.com/1424-8247/17/6/795#supplementary
article html file updated 17 June 2024 13:15 CEST Original file https://www.mdpi.com/1424-8247/17/6/795/html
Back to TopTop